Shi, L., Lin, H., Li, G., Sun, Y., Shen, J., Xu, J., . . . Chang, C. (2016). Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals. Cancer Lett.
Styl ChicagoShi, Liang, Hui Lin, Gonghui Li, Yin Sun, Jiliang Shen, Junjie Xu, Shuyuan Yeh, Xiujun Cai, a Chawnshang Chang. "Cisplatin Enhances NK Cells Immunotherapy Efficacy to Suppress HCC Progression Via Altering the Androgen Receptor (AR)-ULBP2 Signals." Cancer Lett 2016.
Citace podle MLAShi, Liang, et al. "Cisplatin Enhances NK Cells Immunotherapy Efficacy to Suppress HCC Progression Via Altering the Androgen Receptor (AR)-ULBP2 Signals." Cancer Lett 2016.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..